A cross sectional study to evaluate the clinical presentation in multisystem inflammatory syndrome in children

Ambika Sood, Pancham Kumar, Rakesh Sharma, Deepak Sharma, Sanya Sharma


Background: MIS-C as a disease has varied symptoms and signs that affect multiple organs and systems in the body. The present study aimed to describe the clinical presentation among children admitted as a case of multisystem inflammatory syndrome in children in Indira Gandhi Medical College, Shimla.

Methods: We conducted a cross sectional study of children with MIS-C from January to July 2021, in the pediatric ward of Indira Gandhi Medical College Shimla in Himachal Pradesh. All children admitted with a diagnosis of MISC were included in the study. Data regarding clinical presentation was extracted and analyzed using Epi Info V7 software.

Results: In the present study, a total of 31 children diagnosed and admitted as a case of multisystem inflammatory syndrome in children (MIS-C) were included. Mean age of these children was 7.12±4.78 years. Among the total 16 (51.6%) were males while 15 (48.4%) were females. All 31 patients had presented with fever and 13 (41.9%) patients had fever with rash. 5 (16.1%) had cough, 1 (3.2%) child presented with hematemesis, 18 (58.1%) had tachypnea at presentation and 15 (48.4%) patients had respiratory distress. 16 (51.6%) children had complaints of vomiting, 1 (3.2%) presented with bleeding diathesis and 12 (38.7%) had hematuria, 5 (16.1%) had seizures and 8 (25.8%) presented with encephalopathy. 19 (61.3%) children had hypotension, 15 (48.4%) had hepatomegaly and 15 (48.4%) had splenomegaly.

Conclusions: It is very essential to characterize this syndrome to fully understand its spectrum, therefore we need to be continuously watchful for its varied clinical presentations, both for ensuring an early diagnosis and treatment of patients suffering from MIS-C.


Clinical presentation, Multisystem inflammatory syndrome in children, fever, COVID-19

Full Text:



La Rovere KL, Riggs BJ, Poussaint TY. Neurologic involvement in children and adolescents hospitalized in the united states for COVID-19 or Multisystem inflammatory syndrome. JAMA Neurol. 2021;78(5):536-47.

Childrens hospital. Available at: https://www. conditions/m/mis-c. Accessed on 21 July 2021.

MIS-C. Available at: diseases-conditions/mis-c-in-kids-covid-19/ symptoms-causes/syc-20502550. Accessed on 22 July 2021.

MIS-C. Available at: matory-syndrome-in-children-and-adolescents-with-covid-19. Accessed on 23 July 2021.

Health conditions. Available at: https://www.hopkins virus/misc-and-covid19-rare-inflammatory-syndrome -in-kids-and-teens. Accessed on 24 July 2021.

MIS-C. Available at: Accessed on 25 July 2021.

Health Blog. Available at: https://healthblog. Accessed on 26 July 2021.

Levi H, Ruben VP, Filomeen H. Multisystem inflammatory syndrome in children related to COVID-19:a systematic review. Eur J Pediatr. 2021;14:45-51.

Fouriki A, Fougère Y, De Camaret C, Blanchard Rohner G, Grazioli S, Wagner N, et al. Case report: case series of children with multisystem inflammatory syndrome following SARS-CoV-2 Infection in Switzerland. Front Pediatr. 2021;8:594127.

Leora R. Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) Compared with severe acute COVID-19 JAMA. 2021;325(11):1074-87.

Ahmed M. Multisystem inflammatory syndrome in children: A systematic review Clin Med. 2020; 26(2020):100527.

MIS-C and COVID-19. .Available at: Accessed on 22 July 2021.